Siponimod
Novartis BAF312 reduces the risk of disability progression in pivotal phase III study in secondary progressive Multiple Sclerosis patients
Novartis BAF312 reduces the risk of disability progression in pivotal phase III study in secondary progressive Multiple Sclerosis patients
NUI Galway are looking for people to take part in a new programme
If you are a member of MS Ireland, you will have received the AGM notice and information pack together with the new Constitution and Proxy Form as referred in the Notice of the AGM, please see below further information.
Do you or someone you know use Assistive Technology to support them in their daily lives?
This week Declan Groeger considers peace of mind and not letting life get him down.
© 2010 - 2024 Multiple Sclerosis Society of Ireland